BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fifteen research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $18.50.
BTSG has been the topic of a number of recent research reports. UBS Group boosted their target price on shares of BrightSpring Health Services from $16.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. KeyCorp assumed coverage on shares of BrightSpring Health Services in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Wells Fargo & Company upped their price objective on shares of BrightSpring Health Services from $17.00 to $21.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Mizuho lifted their target price on BrightSpring Health Services from $17.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, Bank of America boosted their price target on BrightSpring Health Services from $19.00 to $21.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th.
Get Our Latest Analysis on BrightSpring Health Services
Hedge Funds Weigh In On BrightSpring Health Services
BrightSpring Health Services Trading Up 3.5 %
NASDAQ:BTSG opened at $18.56 on Monday. The business’s 50-day moving average is $17.49 and its two-hundred day moving average is $14.08. The firm has a market capitalization of $3.23 billion and a PE ratio of -71.38. BrightSpring Health Services has a 12 month low of $7.85 and a 12 month high of $20.25. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last announced its earnings results on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.07). The company had revenue of $2.91 billion for the quarter, compared to analysts’ expectations of $2.72 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The company’s quarterly revenue was up 28.8% on a year-over-year basis. Research analysts predict that BrightSpring Health Services will post 0.59 earnings per share for the current fiscal year.
BrightSpring Health Services Company Profile
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Featured Articles
- Five stocks we like better than BrightSpring Health Services
- How to Calculate Options Profits
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Comparing and Trading High PE Ratio Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.